Launch of two new PCR COVID-19 assays

Paris, France and Camberley, UK – 3 June 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of two new polymerase chain reaction (PCR) assays, expanding its genesig® COVID-19 and SNPsig® SARS-CoV-2 variant detection portfolios. http://novacyt.com/wp-content/uploads/2021/06/Novacyt-Launch-of-two-new-PCR-COVID-19-assays-final.pdf

Visit Page